Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
碳酸酐酶 9 作为循环生物标志物和治疗靶点在接受阿特珠单抗联合贝伐珠单抗治疗的肝细胞癌患者中的应用
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013384
Sato, Yu; Kodama, Takahiro; Maesaka, Kazuki; Kai, Machiko; Murai, Kazuhiro; Tahata, Yuki; Saito, Yoshinobu; Nakabori, Tasuku; Ohkawa, Kazuyoshi; Tanaka, Satoshi; Sakamori, Ryotaro; Miyazaki, Masanori; Furuta, Kunimaro; Ishida, Hisashi; Matsumoto, Kengo; Tawara, Seiichi; Yakushijin, Takayuki; Nozaki, Yasutoshi; Hosui, Atsushi; Nishio, Akira; Tatsumi, Nobuyuki; Kakita, Naruyasu; Yoo, Changhoon; Fukai, Moto; Taketomi, Akinobu; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo
